Astellas Pharma’s agreement aims to improve medicine affordability, strengthen critical drug supply chains and support continued investment in innovative therapies.
US Pharmaceutical Supply Chain | 03/09/2026 | By Akanki
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy